CHUGAI PHARMACEUTICAL CO LTD (CHGCF:OTCMKTS)
$56.485 -1.0125 (-1.7609%)
Analysed CHUGAI PHARMACEUTICAL CO LTD (CHGCF:OTCMKTS) News Sources
Mitsubishi Electric Announces Director Candidates
30-03-2026
yahoo.com
Rani Therapeutics Q4 Earnings Call Highlights
26-03-2026
marketbeat.com
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update
26-03-2026
yahoo.com
Roche stops work on experimental SMA drug
20-03-2026
biopharmadive.com
Why Sarepta Therapeutics (SRPT) Is Down 11.2% After CEO Retirement Plan And Japan Gene Therapy Launch - And What's Next
01-03-2026
yahoo.com
Sarepta Therapeutics Announces Commercial Launch of ELEVIDYS in Japan
24-02-2026
yahoo.com
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer
28-01-2026
yahoo.com
Assessing Chugai Pharmaceutical (TSE:4519) Valuation Following Strong Share Price Gains
11-11-2025
yahoo.com
RANI: Third Quarter Results
10-11-2025
yahoo.com
Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update
06-11-2025
yahoo.com
What is the current price of CHUGAI PHARMACEUTICAL CO LTD (CHGCF:OTCMKTS)?
The current price of CHUGAI PHARMACEUTICAL CO LTD (CHGCF:OTCMKTS) is $56.485.
CHUGAI PHARMACEUTICAL CO LTD (CHGCF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CHUGAI PHARMACEUTICAL CO LTD (CHGCF:OTCMKTS) since the previous trading day is $-1.0125.
CHUGAI PHARMACEUTICAL CO LTD (CHGCF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CHUGAI PHARMACEUTICAL CO LTD (CHGCF:OTCMKTS) since the previous trading day is -1.7609%.
What is the most recent average sentiment score for CHUGAI PHARMACEUTICAL CO LTD (CHGCF:OTCMKTS)?
The most recent average sentiment score for CHUGAI PHARMACEUTICAL CO LTD (CHGCF:OTCMKTS) is 70 out of 100.
What is the most recent average sentiment for CHUGAI PHARMACEUTICAL CO LTD (CHGCF:OTCMKTS)?
The most recent sentiment for CHUGAI PHARMACEUTICAL CO LTD (CHGCF:OTCMKTS) is .
SEC-8K** Filing Available For CHUGAI PHARMACEUTICAL CO LTD (CHGCF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.